Filing Details
- Accession Number:
- 0001209191-23-004219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-20 16:05:14
- Reporting Period:
- 2023-01-19
- Accepted Time:
- 2023-01-20 16:05:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1322505 | Albireo Pharma Inc. | ALBO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1443705 | N.r. Simon Harford | C/O Albireo Pharma, Inc. 53 State Street, 19Th Floor Boston MA 02109 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-19 | 1,776 | $43.80 | 32,791 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Represents 13,497 shares of common stock and 19,294 restricted stock units. Includes 1,272 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on November 30, 2022.
Billionaire Hedge Funds
